1 line
3.9 KiB
JSON
1 line
3.9 KiB
JSON
{"accidental exposure to product": 13.0, "adverse drug reaction": 4.48, "anaphylactic reaction": 2.04, "aphonia": 2.56, "asphyxia": 7.19, "asthma": 40.09, "asthmatic crisis": 137.35, "atelectasis": 3.43, "back pain": 2.0, "blood immunoglobulin e increased": 5.58, "blood lactic acid increased": 15.89, "blood potassium decreased": 4.37, "blood test abnormal": 2.46, "breath sounds abnormal": 33.08, "bronchial obstruction": 22.06, "bronchial wall thickening": 26.77, "bronchiectasis": 10.08, "bronchitis": 5.7, "bronchopulmonary aspergillosis allergic": 30.58, "bronchospasm": 7.38, "cardiac operation": 2.53, "chest discomfort": 2.89, "chest x-ray abnormal": 19.24, "choking": 7.46, "choking sensation": 4.11, "chronic obstructive pulmonary disease": 3.63, "chronic sinusitis": 15.13, "circumstance or information capable of leading to medication error": 4.42, "condition aggravated": 4.55, "coronavirus infection": 9.63, "coronavirus test positive": 35.27, "cough": 4.32, "cystitis": 3.18, "decreased activity": 2.01, "decreased immune responsiveness": 2.01, "disease recurrence": 2.63, "drug effective for unapproved indication": 3.81, "dysphonia": 2.71, "dyspnoea": 3.69, "dyspnoea exertional": 3.69, "ear pruritus": 24.74, "eczema": 4.11, "emphysema": 4.42, "endotracheal intubation": 4.29, "eosinophil count abnormal": 54.2, "eosinophil count decreased": 24.42, "eosinophil count increased": 19.2, "eosinophilia": 5.66, "eosinophilic granulomatosis with polyangiitis": 62.72, "exposure via skin contact": 108.89, "eye pruritus": 4.32, "fear of injection": 11.36, "forced expiratory volume decreased": 9.73, "full blood count abnormal": 34.78, "hospitalisation": 7.07, "ill-defined disorder": 4.77, "illness": 2.54, "immune system disorder": 2.2, "inappropriate schedule of product administration": 3.76, "incorrect dose administered": 2.16, "incorrect product administration duration": 3.0, "increased bronchial secretion": 7.9, "injection site bruising": 2.02, "injection site discomfort": 2.23, "injection site urticaria": 2.83, "kidney infection": 2.92, "lacrimation increased": 2.67, "laryngeal oedema": 2.31, "loss of personal independence in daily activities": 13.69, "lower respiratory tract infection": 4.01, "lung disorder": 4.01, "middle insomnia": 3.59, "multiple allergies": 14.32, "nasal congestion": 7.29, "nasal polyps": 98.69, "nasopharyngitis": 2.58, "obstructive airways disorder": 31.16, "oxygen saturation decreased": 3.28, "peak expiratory flow rate decreased": 57.85, "pharyngitis": 3.42, "platelet count increased": 4.7, "pneumonia": 3.83, "pneumonia bacterial": 2.41, "pneumothorax": 2.01, "polymyalgia rheumatica": 2.06, "polyp": 7.13, "product availability issue": 17.01, "product complaint": 18.76, "product dose omission issue": 11.87, "product use in unapproved indication": 2.96, "productive cough": 13.78, "prostate cancer": 2.08, "pulmonary congestion": 6.15, "pulmonary function test abnormal": 52.06, "pulmonary function test decreased": 5.44, "pulmonary mass": 3.75, "quality of life decreased": 3.68, "respiratory disorder": 4.53, "respiratory symptom": 9.3, "respiratory tract congestion": 5.05, "respiratory tract infection": 4.27, "rhinitis": 3.01, "rhinitis allergic": 17.33, "rhinorrhoea": 2.87, "scratch": 4.15, "seasonal allergy": 5.7, "secretion discharge": 12.33, "sinus congestion": 3.41, "sinus disorder": 3.36, "sinusitis": 6.65, "skin lesion": 2.46, "sleep disorder due to a general medical condition": 104.13, "sneezing": 6.4, "social problem": 46.7, "spinal operation": 2.95, "sputum discoloured": 23.81, "surgery": 3.44, "symptom recurrence": 9.57, "therapeutic product effect decreased": 2.01, "therapeutic product effect incomplete": 19.58, "therapeutic response unexpected": 3.26, "therapy cessation": 7.14, "therapy interrupted": 14.3, "upper respiratory tract infection": 2.25, "upper-airway cough syndrome": 25.2, "use of accessory respiratory muscles": 19.8, "vasculitis": 4.47, "viral infection": 2.98, "wheezing": 32.52, "wrong technique in device usage process": 20.9} |